{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:50:29Z","timestamp":1792687829858,"version":"4.5.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T00:00:00Z","timestamp":1626307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.pnpbp.2021.110402","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T12:02:28Z","timestamp":1626350548000},"page":"110402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"special_numbering":"C","title":["Thyroid hormones in persons with schizophrenia: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"111","author":[{"given":"B\u0142a\u017cej","family":"Misiak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart\u0142omiej","family":"Sta\u0144czykiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Wi\u015bniewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bartoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Carra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Cavaleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy","family":"Samochowiec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Jarosz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Rosi\u0144czuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Frydecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.pnpbp.2021.110402_bb0005","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.ecl.2007.04.007","article-title":"The nonthyroidal illness syndrome","volume":"36","author":"Adler","year":"2007","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"issue":"4","key":"10.1016\/j.pnpbp.2021.110402_bb0010","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1600-0447.1984.tb01212.x","article-title":"Thyroid stimulation test in healthy subjects and psychiatric patients","volume":"70","author":"Banki","year":"1984","journal-title":"Acta Psychiatr. Scand."},{"issue":"1\u20133","key":"10.1016\/j.pnpbp.2021.110402_bb0015","first-page":"37","article-title":"Free thyroxine levels are associated with cognitive abilities in subjects with early psychosis","volume":"166","author":"Barbero","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2021.110402_bb0020","article-title":"Association between anti-thyroid antibodies and negative symptoms in early psychosis","author":"Barbero","year":"2019","journal-title":"Early Interv. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2021.110402_bb0025","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0920-9964(99)00187-5","article-title":"The hypothalamic-pituitary-thyroid axis in patients with schizophrenia","volume":"44","author":"Baumgartner","year":"2000","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2021.110402_bb0030","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/ncpendmet0424","article-title":"Thyroid hormone receptors in brain development and function","volume":"3","author":"Bernal","year":"2007","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.pnpbp.2021.110402_bb0035","first-page":"141","article-title":"Neuro- and immunomodulatory steroids and other biochemical markers in drug-naive schizophrenia patients and the effect of treatment with atypical antipsychotics","volume":"32","author":"Bi\u010d\u00edkov\u00e1","year":"2011","journal-title":"Neuroendocrinol. Lett."},{"issue":"2","key":"10.1016\/j.pnpbp.2021.110402_bb0040","first-page":"200","article-title":"Thyroid function in different psychiatric disorders","volume":"22","author":"Boral","year":"1980","journal-title":"Indian J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110402_bb0045","doi-asserted-by":"crossref","first-page":"7250","DOI":"10.1073\/pnas.86.18.7250","article-title":"Differential expression of \u03b1 and \u03b2 thyroid hormone receptor genes in rat brain and pituitary","volume":"86","author":"Bradley","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pnpbp.2021.110402_bb0050","first-page":"261","article-title":"Effects of hormones on cognition in schizophrenic male patients\u2014preliminary results","volume":"27","author":"Bratek","year":"2015","journal-title":"Psychiatr. Danub."},{"issue":"1","key":"10.1016\/j.pnpbp.2021.110402_bb0055","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3111\/13696998.2011.632042","article-title":"Association between second-generation antipsychotic medication half-life and hospitalization in the community treatment of adult schizophrenia","volume":"15","author":"Broder","year":"2012","journal-title":"J. Med. Econ."},{"issue":"6","key":"10.1016\/j.pnpbp.2021.110402_bb0060","doi-asserted-by":"crossref","first-page":"101364","DOI":"10.1016\/j.beem.2019.101364","article-title":"Thyroid gland and brain: enigma of Hashimoto\u2019s encephalopathy","volume":"33","author":"Churilov","year":"2019","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.pnpbp.2021.110402_bb0065","doi-asserted-by":"crossref","first-page":"614030","DOI":"10.3389\/fcell.2020.614030","article-title":"Thyroid hormones interaction with immune response, inflammation and non-thyroidal illness syndrome","volume":"8","author":"De Luca","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.pnpbp.2021.110402_bb0070","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.psychres.2019.03.027","article-title":"Prolactin levels in drug-na\u00efve first episode nonaffective psychosis patients compared with healthy controls. Sex differences","volume":"276","author":"Del Cacho","year":"2019","journal-title":"Psychiatry Res."},{"issue":"1","key":"10.1016\/j.pnpbp.2021.110402_bb0075","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0165-1781(91)90051-P","article-title":"Familial thyroid disease and delayed language development in first admission patients with schizophrenia","volume":"38","author":"DeLisi","year":"1991","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2021.110402_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/1096-8628(20000612)96:3<398::AID-AJMG30>3.0.CO;2-Z","article-title":"Investigation of a candidate gene for schizophrenia on Xq13 previously associated with mental retardation and hypothyroidism","author":"DeLisi","year":"2000","journal-title":"Am. J. Med. Genet. Neuropsychiatr. Genet."},{"key":"10.1016\/j.pnpbp.2021.110402_bb0085","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/jne.12283","article-title":"Thyroid hormone and astroglia: endocrine control of the neural environment","volume":"27","author":"Dezonne","year":"2015","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.pnpbp.2021.110402_bb0090","series-title":"The Essential Guide to Effect Sizes: Statistical Power, Meta-Analysis, and the Interpretation of Research Results","author":"Ellis","year":"2010"},{"issue":"7","key":"10.1016\/j.pnpbp.2021.110402_bb0095","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00406-020-01113-2","article-title":"Autoimmune encephalitis as a differential diagnosis of schizophreniform psychosis: clinical symptomatology, pathophysiology, diagnostic approach, and therapeutic considerations","volume":"270","author":"Endres","year":"2020","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2021.110402_bb0100","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1210\/endo.137.8.8754744","article-title":"Isoform-specific 3,5,3\u2032-triiodothyronine receptor binding capacity and messenger ribonucleic acid content in rat adenohypophysis: effect of thyroidal state and comparison with extrapituitary tissues","volume":"137","author":"Ercan-Fang","year":"1996","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.pnpbp.2021.110402_bb0105","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1001\/archpsyc.1982.04290010053010","article-title":"Using the protirelin test to distinguish mania from schizophrenia","volume":"39","author":"Extein","year":"1982","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110402_bb0110","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3389\/fendo.2017.00050","article-title":"Environmental issues in thyroid diseases","volume":"8","author":"Ferrari","year":"2017","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.pnpbp.2021.110402_bb0115","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jclinepi.2010.08.010","article-title":"Conducting quantitative synthesis when comparing medical interventions: AHRQ and the Effective Health Care Program","volume":"64","author":"Fu","year":"2011","journal-title":"J. Clin. Epidemiol."},{"issue":"1","key":"10.1016\/j.pnpbp.2021.110402_bb0120","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.schres.2011.07.025","article-title":"Prolactin concentrations in newly diagnosed, antipsychotic-na\u00efve patients with nonaffective psychosis","volume":"134","author":"Garcia-Rizo","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2021.110402_bb0125","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.schres.2016.03.018","article-title":"Prolactin concentrations in antipsychotic-na\u00efve patients with schizophrenia and related disorders: a meta-analysis","volume":"174","author":"Gonz\u00e1lez-Blanco","year":"2016","journal-title":"Schizophr. Res."},{"issue":"5","key":"10.1016\/j.pnpbp.2021.110402_bb0130","first-page":"461","article-title":"Neuroendocrine response to antipsychotics: effects of drug type and gender","volume":"28","author":"Gr\u00fcnder","year":"1999","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2021.110402_bb0135","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/00019616-199605000-00008","article-title":"The interface between thyroid hormones and psychiatry","volume":"6","author":"Hennessey","year":"1996","journal-title":"Endocrinologist"},{"key":"10.1016\/j.pnpbp.2021.110402_bib381","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2019"},{"key":"10.1016\/j.pnpbp.2021.110402_bb0145","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.pnpbp.2021.110402_bb0150","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.psyneuen.2019.03.014","article-title":"Meta-analysis of blood cortisol levels in individuals with first-episode psychosis","volume":"104","author":"Hubbard","year":"2019","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.pnpbp.2021.110402_bb0155","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.pnpbp.2012.06.008","article-title":"Triiodothyronine may be possibly associated with better cognitive function and less extrapyramidal symptoms in chronic schizophrenia","volume":"39","author":"Ichioka","year":"2012","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110402_bb0160","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.cca.2015.02.003","article-title":"Association between prolactin and thyroid hormones with severity of psychopathology and suicide risk in drug free male schizophrenia","volume":"444","author":"Jose","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.pnpbp.2021.110402_bb0165","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.psychres.2019.02.029","article-title":"Association between thyroid function and metabolic syndrome in male and female schizophrenia patients","volume":"274","author":"Kalinowska","year":"2019","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2021.110402_bb0170","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"6","key":"10.1016\/j.pnpbp.2021.110402_bb0175","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/WNF.0b013e31823429a7","article-title":"Thyroid adverse effects of psychotropic drugs: a review","volume":"34","author":"Khalil","year":"2011","journal-title":"Clin. Neuropharmacol."},{"issue":"6","key":"10.1016\/j.pnpbp.2021.110402_bb0180","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/pcn.12847","article-title":"Acute psychosis in patients with subclinical hyperthyroidism","volume":"73","author":"Kimoto","year":"2019","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"1\u20133","key":"10.1016\/j.pnpbp.2021.110402_bb0185","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.schres.2016.01.036","article-title":"Free thyroxine levels are associated with cognitive changes in individuals with a first episode of psychosis: a prospective 1-year follow-up study","volume":"171","author":"Labad","year":"2016","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2021.110402_bb0190","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3389\/fpsyg.2013.00863","article-title":"Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs","volume":"4","author":"Lakens","year":"2013","journal-title":"Front. Psychol."},{"issue":"5","key":"10.1016\/j.pnpbp.2021.110402_bb0195","first-page":"1165","article-title":"Inhibition of thyroxine transport into cultured rat hepatocytes by serum of nonuremic critically ill patients: effects of bilirubin and nonesterified fatty acids","volume":"76","author":"Lim","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.pnpbp.2021.110402_bb0200","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.1038\/s41598-019-40691-7","article-title":"Long-term use of clozapine is protective for bone density in patients with schizophrenia","volume":"9","author":"Lin","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pnpbp.2021.110402_bb0205","doi-asserted-by":"crossref","first-page":"104744","DOI":"10.1016\/j.psyneuen.2020.104744","article-title":"Impaired hormonal regulation of appetite in schizophrenia: a narrative review dissecting intrinsic mechanisms and the effects of antipsychotics","volume":"119","author":"Lis","year":"2020","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"10.1016\/j.pnpbp.2021.110402_bb0210","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0306-4530(77)90019-1","article-title":"Thyroid stimulating hormone response after thyrotropin releasing hormone in depressed, schizophrenic and normal women","volume":"2","author":"Loosen","year":"1977","journal-title":"Psychoneuroendocrinology"},{"issue":"3","key":"10.1016\/j.pnpbp.2021.110402_bb0215","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/schbul\/sbp017","article-title":"What we know: findings that every theory of schizophrenia should explain","volume":"35","author":"MacDonald","year":"2009","journal-title":"Schizophr. Bull."},{"issue":"4","key":"10.1016\/j.pnpbp.2021.110402_bb0220","first-page":"440","article-title":"Hyperthyroidism--cause of depression and psychosis: a case report","volume":"2","author":"Marian","year":"2009","journal-title":"J. Med. Life"},{"key":"10.1016\/j.pnpbp.2021.110402_bb0225","doi-asserted-by":"crossref","first-page":"113356","DOI":"10.1016\/j.psychres.2020.113356","article-title":"Thyroid function assessment before and after diagnosis of schizophrenia: a community-based study","volume":"293","author":"Melamed","year":"2020","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2021.110402_bb0230","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.psyneuen.2018.01.007","article-title":"Testosterone, DHEA and DHEA-S in patients with schizophrenia: a systematic review and meta-analysis","volume":"89","author":"Misiak","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pnpbp.2021.110402_bb0235","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.neubiorev.2019.05.018","article-title":"Appetite regulating hormones in first-episode psychosis: a systematic review and meta-analysis","volume":"102","author":"Misiak","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"7","key":"10.1016\/j.pnpbp.2021.110402_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.pnpbp.2021.110402_bb0245","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3389\/fncel.2015.00194","article-title":"Possible role of glial cells in the relationship between thyroid dysfunction and mental disorders","volume":"9","author":"Noda","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.pnpbp.2021.110402_bb0250","series-title":"Vitamins and Hormones","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/bs.vh.2017.05.005","article-title":"Thyroid hormone in the CNS: contribution of neuron\u2013glia interaction","volume":"106","author":"Noda","year":"2018"},{"issue":"2","key":"10.1016\/j.pnpbp.2021.110402_bb0255","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1365-2362.2010.02395.x","article-title":"The nonthyroidal illness syndrome in the non-critically ill patient","volume":"41","author":"Pappa","year":"2011","journal-title":"Eur. J. Clin. Investig."},{"issue":"3","key":"10.1016\/j.pnpbp.2021.110402_bb0260","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00004850-199100630-00001","article-title":"Neuroleptic actions on the thyroid axis: different effects of clozapine and haloperidol","volume":"6","author":"Paunovl\u0107","year":"1991","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.pnpbp.2021.110402_bb0265","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/13651501.2016.1197274","article-title":"Prolactin levels in drug-na\u00efve patients with schizophrenia and other psychotic disorders","volume":"20","author":"Petrikis","year":"2016","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"10.1016\/j.pnpbp.2021.110402_bb0270","doi-asserted-by":"crossref","first-page":"108","DOI":"10.24869\/psyd.2017.108","article-title":"Causes of mortality in schizophrenia: an updated review of European studies","volume":"29","author":"Piotrowski","year":"2017","journal-title":"Psychiatr. Danub."},{"issue":"10","key":"10.1016\/j.pnpbp.2021.110402_bb0275","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1001\/archpsyc.1979.01780100056005","article-title":"Behavioral and endocrine responses of schizophrenic patients to TRH (protirelin)","volume":"36","author":"Prange","year":"1979","journal-title":"Arch. Gen. Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2021.110402_bb0280","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0006-3223(89)90211-4","article-title":"TRH test in schizophrenic patients and controls","volume":"25","author":"Roy","year":"1989","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2021.110402_bb0285","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/ajmg.b.20019","article-title":"Polymorphism analysis ofHOPA: a candidate gene for schizophrenia","volume":"123B","author":"Sandhu","year":"2003","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.pnpbp.2021.110402_bb0290","article-title":"Revisiting thyroid hormones in schizophrenia","volume":"569147","author":"Santos","year":"2012","journal-title":"J. Thyroid. Res."},{"issue":"2","key":"10.1016\/j.pnpbp.2021.110402_bb0295","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1017\/S1092852920000279","article-title":"109 hyperthyroidism-induced psychosis","volume":"25","author":"Shaikh","year":"2020","journal-title":"CNS Spectr."},{"issue":"6","key":"10.1016\/j.pnpbp.2021.110402_bb0305","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s12026-018-9030-7","article-title":"The link between schizophrenia and hypothyroidism: a population-based study","volume":"66","author":"Sharif","year":"2018","journal-title":"Immunol. Res."},{"issue":"4","key":"10.1016\/j.pnpbp.2021.110402_bb0310","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11739-009-0259-y","article-title":"Psychosis as the first presentation of hyperthyroidism","volume":"4","author":"Snabboon","year":"2009","journal-title":"Intern. Emerg. Med."},{"key":"10.1016\/j.pnpbp.2021.110402_bb0315","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.3389\/fimmu.2019.02349","article-title":"The impact of obesity on thyroid autoimmunity and dysfunction: a systematic review and meta-analysis","volume":"10","author":"Song","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.pnpbp.2021.110402_bb0320","series-title":"Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series","article-title":"Addressing reporting biases","author":"Sterne","year":"2008"},{"issue":"2","key":"10.1016\/j.pnpbp.2021.110402_bb0325","first-page":"312","article-title":"Thyroid hormone levels in chronic schizophrenic patients: association with psychopathology","volume":"65","author":"Telo","year":"2016","journal-title":"West Indian Med. J."},{"key":"10.1016\/j.pnpbp.2021.110402_bb0330","series-title":"StatPearls [Internet]","article-title":"Case control studies","author":"Tenny","year":"2020"},{"key":"10.1016\/j.pnpbp.2021.110402_bb0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40261-019-00854-w","article-title":"Targeting hormones for improving cognition in major mood disorders and schizophrenia: thyroid hormones and prolactin","volume":"40","author":"Tost","year":"2020","journal-title":"Clin. Drug Investig."},{"issue":"1\u20133","key":"10.1016\/j.pnpbp.2021.110402_bb0340","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.schres.2014.03.005","article-title":"2014. Cytokine function in medication-naive first episode psychosis: a systematic review and meta-analysis","volume":"155","author":"Upthegrove","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2021.110402_bb0345","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jpsychires.2018.09.014","article-title":"Free thyroxine and thyroid-stimulating hormone in severe mental disorders: a naturalistic study with focus on antipsychotic medication","volume":"106","author":"Vedal","year":"2018","journal-title":"J. Psychiatr. Res."},{"issue":"1","key":"10.1016\/j.pnpbp.2021.110402_bb0350","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0165-0327(88)90012-2","article-title":"Thyrotropin response to thyrotropin-releasing hormone in RDC schizodepressed men","volume":"15","author":"Wahby","year":"1988","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2021.110402_bb0355","author":"Wells"},{"issue":"5","key":"10.1016\/j.pnpbp.2021.110402_bb0360","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0022-3956(94)90004-3","article-title":"Acute antagonism of dopamine D2-like receptors by amisulpride: effects on hormone secretion in healthy volunteers","volume":"28","author":"Wetzel","year":"1994","journal-title":"J. Psychiatr. Res."},{"issue":"3","key":"10.1016\/j.pnpbp.2021.110402_bb0365","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0278-5846(01)00311-6","article-title":"Different neuroendocrine profiles of remitted and nonremitted schizophrenic patients","volume":"26","author":"Yazici","year":"2002","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatry"},{"issue":"10","key":"10.1016\/j.pnpbp.2021.110402_bb0370","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s40618-014-0133-2","article-title":"Pituitary side effects of old and new drugs","volume":"37","author":"Zatelli","year":"2014","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.pnpbp.2021.110402_bb0375","doi-asserted-by":"crossref","DOI":"10.1111\/bcp.14928","article-title":"Dose-response association of acute-phase quetiapine treatment with risk of new-onset hypothyroidism in schizophrenia patients","author":"Zhao","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.pnpbp.2021.110402_bb0380","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fpsyt.2020.00065","article-title":"Functional status of hypothalamic\u2013pituitary\u2013thyroid and hypothalamic\u2013pituitary\u2013adrenal axes in hospitalized schizophrenics in Shanghai","volume":"11","author":"Zhu","year":"2020","journal-title":"Front. Psychiatry"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584621001615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584621001615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T20:04:40Z","timestamp":1759521880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584621001615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":75,"alternative-id":["S0278584621001615"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2021.110402","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thyroid hormones in persons with schizophrenia: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2021.110402","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110402"}}